Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty
- Department of Medical Physics, Faculty of Medicine, University of Crete, P.O. Box 2208, 71003 Iraklion, Crete (Greece)
- Department of Radiotherapy and Oncology, University Hospital of Iraklion, 71110 Iraklion, Crete (Greece)
Purpose: Heterotopic ossification (HO) is a frequent complication following total hip arthroplasty. This study was conducted to calculate the radiation dose to organs-at-risk and estimate the probability of cancer induction from radiotherapy for HO prophylaxis.Methods: Hip irradiation for HO with a 6 MV photon beam was simulated with the aid of a Monte Carlo model. A realistic humanoid phantom representing an average adult patient was implemented in Monte Carlo environment for dosimetric calculations. The average out-of-field radiation dose to stomach, liver, lung, prostate, bladder, thyroid, breast, uterus, and ovary was calculated. The organ-equivalent-dose to colon, that was partly included within the treatment field, was also determined. Organ dose calculations were carried out using three different field sizes. The dependence of organ doses upon the block insertion into primary beam for shielding colon and prosthesis was investigated. The lifetime attributable risk for cancer development was estimated using organ, age, and gender-specific risk coefficients.Results: For a typical target dose of 7 Gy, organ doses varied from 1.0 to 741.1 mGy by the field dimensions and organ location relative to the field edge. Blocked field irradiations resulted in a dose range of 1.4–146.3 mGy. The most probable detriment from open field treatment of male patients was colon cancer with a high risk of 564.3 × 10{sup −5} to 837.4 × 10{sup −5} depending upon the organ dose magnitude and the patient's age. The corresponding colon cancer risk for female patients was (372.2–541.0) × 10{sup −5}. The probability of bladder cancer development was more than 113.7 × 10{sup −5} and 110.3 × 10{sup −5} for males and females, respectively. The cancer risk range to other individual organs was reduced to (0.003–68.5) × 10{sup −5}.Conclusions: The risk for cancer induction from radiation therapy for HO prophylaxis after total hip arthroplasty varies considerably by the treatment parameters, organ site in respect to treatment volume and patient's gender and age. The presented risk estimates may be useful in the follow-up studies of irradiated patients.
- OSTI ID:
- 22220403
- Journal Information:
- Medical Physics, Journal Name: Medical Physics Journal Issue: 10 Vol. 40; ISSN 0094-2405; ISSN MPHYA6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma
Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas
Risks of secondary malignancies with heterotopic bone radiation therapy for patients younger than 40 years
Journal Article
·
Thu May 15 00:00:00 EDT 2014
· Medical Physics
·
OSTI ID:22250758
Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas
Journal Article
·
Fri Apr 15 00:00:00 EDT 2016
· Medical Physics
·
OSTI ID:22620849
Risks of secondary malignancies with heterotopic bone radiation therapy for patients younger than 40 years
Journal Article
·
Sat Oct 01 00:00:00 EDT 2016
· Medical Dosimetry
·
OSTI ID:22685149
Related Subjects
61 RADIATION PROTECTION AND DOSIMETRY
62 RADIOLOGY AND NUCLEAR MEDICINE
BLADDER
DOSE EQUIVALENTS
DOSIMETRY
HEALTH HAZARDS
LARGE INTESTINE
LIVER
LUNGS
MAMMARY GLANDS
MONTE CARLO METHOD
NEOPLASMS
OVARIES
PATIENTS
PHANTOMS
PHOTON BEAMS
PREVENTIVE MEDICINE
PROSTATE
RADIATION DOSES
RADIOTHERAPY
STOMACH
THYROID
UTERUS
62 RADIOLOGY AND NUCLEAR MEDICINE
BLADDER
DOSE EQUIVALENTS
DOSIMETRY
HEALTH HAZARDS
LARGE INTESTINE
LIVER
LUNGS
MAMMARY GLANDS
MONTE CARLO METHOD
NEOPLASMS
OVARIES
PATIENTS
PHANTOMS
PHOTON BEAMS
PREVENTIVE MEDICINE
PROSTATE
RADIATION DOSES
RADIOTHERAPY
STOMACH
THYROID
UTERUS